AzTrials
AzTrials

Metabolic DisturbancePhase 1/2IMHNCT05070585

Isothiocyanates and Metabolic Health

A Phase 1/2 study testing Isothiocyanate rich sprouts in people with Metabolic Disturbance, run by The Swedish School of Sport and Health Sciences at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Many sprouts, for example broccoli sprouts, contain substances that have shown to have protective effects, both against oxidative stress and against carcinogenic substances. In this study we will investigate the activation of the body's antioxidant defense system and effect on blood lactate and glucose after 1 week of… Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Metabolic Disturbance
What is being tested?
Isothiocyanate rich sprouts
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
12 participants
Where
1 siteSweden
Study dates
20 Oct 2021to 5 Dec 2023
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy volunteer
  • 18-45 years old

Who cannot join

  • Any chronic disease
  • Inability to perform cycling exercise
  • Allergic to anesthesia

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Swedish School of Sports and Health Sciences

    Stockholm, 114 86

Other trials in Sweden

About this study

Many sprouts, for example broccoli sprouts, contain substances that have shown to have protective effects, both against oxidative stress and against carcinogenic substances.

In this study we will investigate the activation of the body's antioxidant defense system and effect on blood lactate and glucose after 1 week of isothiocyanate rich sprout supplementation. The subjects will perform maximal and submaximal work test, blood sampling, muscle biopsies and blood pressure monitoring post supplementation. We hypothesize that 1 week of supplementation of isothiocyanate rich sprouts alters blood lactate and glucose metabolism and activates the body's antioxidant defense system.

Read the detailed description

Many sprouts, for example broccoli sprouts, contain high levels of glucosinolates, which can be converted to the bioactive substances isothiocyanates. This conversion is assisted by another plant enzyme, myrosinase, which is released when the plant is mechanically processed. It is believed that this reaction is part of the plant's natural defense against pest insects and other animals that attack the plant in the early developmental stage. In cell and animal studies supplementation with isothiocyanates has been shown to induce the protein Nrf2 which is a so-called "Master regulator" of the body's antioxidant defenses and activates more than 200 genes that together provide a strong protection against oxidative and mutagenic stress.

In this study we will investigate Nrf2 activation in human skeletal muscle and effect on lactate-, glucose metabolism after 1 week of isothiocyanate rich sprout supplementation. The study is a double-blinded, randomized, placebo controlled, cross-over study with 4 weeks wash-out between the interventions. We will perform maximal- and submaximal work test and monitor blood glucose and lactate during the tests. Also, in the post intervention phases we will perform muscle biopsies, glucose tolerance tests and monitor blood pressure.

The hypothesis is that 1 week of isothiocyanate rich sprout supplementation activates Nrf2 in human skeletal muscle and alters blood lactate and glucose metabolism in rest and during exercise.

Being tested
Isothiocyanate rich sprouts, Placebo Juice
Keywords
Isothiocyanates, Blood lactate, Glucose regulation, Nrf2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Isothiocyanate rich sproutsDietary supplement

    Isothiocyanate rich sprout juice consumption for 1 week

  • Placebo JuiceDietary supplement

    Sprout juice devoid of isothiocyanates for 1 week

Study groups in NCT05070585
Study groupRoleWhat they receive
Isothiocyanate Rich JuiceExperimentalThe juices will contain 37,5g isothiocyanate rich sprouts and be delivered frozen to the subjects. The subjects will be instructed to consume two juices per day.
Receives: Dietary Supplement: Isothiocyanate rich sprouts
Placebo JuicePlacebo comparatorThe juices will contain 37,5g alfalfa sprouts and be delivered frozen to the subjects. The subjects will be instructed to consume two juices per day.
Receives: Dietary Supplement: Placebo Juice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Blood lactate

    Changes in blood lactate during exercise

    Measured: Acute during sub maximal exercise

  2. Nrf2 activation

    Increased Nrf2 protein in human skeletal muscle

    Measured: Acute after 1 week of supplementation

  3. Glucose regulation

    Improved continuous glucose control

    Measured: Throughout 1 week of supplementation

Secondary outcomes (2)
  1. Glucose tolerance test

    Improved glucose regulation in rest

    Measured: 120 minutes

  2. Clinic blood pressure

    Blood pressure regulation

    Measured: Acute after 1 week of supplementation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2021
  2. Study start20 Oct 2021
  3. Primary completion1 Dec 2022
  4. Study completion5 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Model description
Randomized, placebo controlled, cross-over study
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05070585
Sponsor's protocol ID
SwedishSchoolSport
Acronym
IMH
Status last verified
Dec 2022
First submitted
1 Sep 2021
Last updated
6 Dec 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Isothiocyanate rich sprouts in people with Metabolic Disturbance, run by The Swedish School of Sport and Health Sciences at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Blood lactate (time frame: Acute during sub maximal exercise). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in